UBC Medical Indonesia Tbk. vs LCK Global Kedaton Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while LCK Global Kedaton Tbk. trades at Rp111 (market cap 107B, 39.11M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5.4× LCK Global Kedaton Tbk.'s market cap, and LCK Global Kedaton Tbk. is more actively traded (39.11M versus 3.48M). Which is the better fit depends on your goals.
| LABS | LCKM | |
|---|---|---|
Market Cap | 576.7B | 107B |
Volume | 3.48M | 39.11M |
Lot | 34.82K | 391.08K |
Turnover | 522.79M | 4.36B |
Average Price | 150.13 | 111.56 |
Value | 522.79M | 4.36B |
Indicative Equilibrium Price | 148 | 111 |
Indicative Equilibrium Volume | 350 | 3.23K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT LCK Global Kedaton (the "Company") was established on July 31, 2013 based on Deed of Establishment no. 44 made before Notary Sahat Simanungkalit, SH, M.Kn
Read more on LCKM →